FAMILY STUDY OF LINKAGE DISEQUILIBRIUM BETWEEN TAP2 TRANSPORTER AND HLA CLASS-II GENES - ABSENCE OF TAP2 CONTRIBUTION TO ASSOCIATION WITH INSULIN-DEPENDENT DIABETES-MELLITUS
S. Caillatzucman et al., FAMILY STUDY OF LINKAGE DISEQUILIBRIUM BETWEEN TAP2 TRANSPORTER AND HLA CLASS-II GENES - ABSENCE OF TAP2 CONTRIBUTION TO ASSOCIATION WITH INSULIN-DEPENDENT DIABETES-MELLITUS, Human immunology, 44(2), 1995, pp. 80-87
The polymorphic TAP1 and TAP2 genes encode a transporter protein requi
red for delivery of cytosolic peptides to class I molecules in the end
oplasmic reticulum. Associations have been observed between TAP2 allel
es and predisposition to autoimmune diseases such as IDDM but their in
terpretation has been complicated by the existence of LD between TAP2
and HLA class II loci, and conclusions are still contradictory. In ord
er to precisely define LD on class II haplotypes, we performed an exte
nsive familial analysis. A total of 466 individuals from 55 normal fam
ilies and 49 IDDM multiplex families was studied, providing informatio
n on 420 independent haplotypes. The IDDM-predisposing DRB103 and DRB
104 alleles were in strong negative LD with TAP2-B (Delta = -0.035 an
d -0.034, respectively), and positive LD with TAP2-A (Delta = -0.055 a
nd +0.012). Positive LD was also found between TAP2-B and DRB101 and
TAP2-C and DRB111 alleles. We then addressed the question of whether
TAP2 is an independent additional IDDM-protective or predisposing gene
tic factor. No TAP2 effect was evidenced when considering DRB103 and/
or 04 patients. A decreased TAP2-B phenotype frequency was observed in
DRB103- and DRB1*04-negative IDDM patients compared with DRB1*03- an
d DRB1O4-negative normal controls (38.6% vs 63%, p(c) < 0.05), but wa
s probably related to a combination of different weak LD between DRB1
and TAP2 alleles. It thus appears that there is no primary association
between TAP2 alleles and IDDM. However, TAP polymorphism may allow us
to define particular extended HLA haplotypes involved in susceptibili
ty to autoimmune diseases.